U.S. practice guide

Source with a checklist, not a hunch.

A practical framework for reviewing an aesthetic supply vendor before price or speed drives the decision.

Professional reviewing a supplier documentation checklist
Short answer: a responsible vendor review should confirm the legal seller, authorized source, product-specific U.S. status, traceable lot information, labeled storage conditions, purchaser restrictions, complaint process and realistic fulfillment terms before an order is placed.

A polished storefront is not evidence that a medical or aesthetic product is authentic, approved for a particular use, or sourced through an authorized channel. U.S. practices need a repeatable review that separates verifiable facts from marketing language. The same checklist should be used for a first order, a new product line and periodic supplier re-approval.

1. Identify the legal seller

Record the company legal name, operating address, support channel, website domain and the entity shown on invoices and payment statements. These details should agree. A vendor that cannot clearly identify the contracting seller creates avoidable problems for recalls, disputes, tax records and adverse-event follow-up.

2. Ask how the product entered the supply chain

Request documentation appropriate to the product type: manufacturer or authorized-distributor relationship, transaction records, product identifiers, lot and expiration controls, and the party responsible for U.S. distribution. Do not treat phrases such as “genuine,” “CE marked,” “European stock” or “same factory” as substitutes for a U.S. authorization and traceability review.

For prescription drugs, FDA advises health professionals to purchase only from wholesale drug distributors licensed in their state and to verify licensure. Drug supply-chain documentation requirements may also apply. Devices and cosmetics follow different frameworks, so the checklist must branch by product classification rather than applying one badge to the entire catalog.

3. Verify the exact U.S. product, not only the brand

Regulatory status is product- and indication-specific. A familiar brand name may cover different formulations, sizes or presentations in different markets. Compare the exact proprietary name, manufacturer, model or strength, packaging language, product code and intended use with authoritative records and current manufacturer information.

This is particularly important for dermal fillers. FDA states that approved filler uses vary by product and that these devices are prescription use. FDA also advises consumers not to buy dermal fillers online for self-injection. A business-facing storefront should therefore avoid language that makes professional restrictions or approved uses look interchangeable.

4. Review packaging, storage and delivery controls

  • Packaging: intact seals, legible labeling and identifiers that match order records.
  • Lot controls: lot and expiration information captured at receiving and linked to the purchase record.
  • Storage: labeled conditions documented through transit, receipt and on-site storage.
  • Exceptions: a written process for damaged, delayed, warm, frozen, opened or questionable shipments.

“Fast shipping” is not a quality system. Ask which carrier services are available, how dispatch cutoffs work, what happens during extreme weather and how the vendor investigates a possible temperature or chain-of-custody exception.

5. Test the claims and account process

Review product claims, before-and-after images, testimonials and badges with the same skepticism you would apply to your own practice marketing. The FTC expects objective health-related claims to be truthful, not misleading and supported by competent and reliable scientific evidence. A supplier should not invent reviews, imply government endorsement or use a certification beyond its actual scope.

For restricted products, a professional-account process should explain what information is required, why it is reviewed, how it is protected and whether approval applies to the account, the product or both. A simple checkbox is not a meaningful control when law or manufacturer policy requires more.

6. Run a low-risk first order

Before consolidating purchasing, place a limited order that exercises the real workflow. Verify confirmation emails, invoice identity, package condition, labeling, lot capture, delivery performance and support response. Document the result. Price becomes comparable only after the cost of verification, exceptions and unusable inventory is included.

A reusable vendor-review record

  • Legal seller and verified contact information
  • State or federal license checks where applicable
  • Authorized-source evidence and date reviewed
  • Exact products approved for purchase by the practice
  • Storage, shipping, returns, complaint and recall process
  • Reviewer, approval date and next re-review date

A “pass” should never be permanent. Re-run the review when ownership changes, a domain changes, payment instructions change, the distributor relationship changes, packaging looks different or an order creates an unexplained exception.

Authoritative starting points: FDA Know Your Source, FDA Dermal Fillers, and FTC Health Products Compliance Guidance. This guide is operational information, not legal or medical advice.